BioSpace News Archive

STEMCELL Technologies Wins a Canada’s Most Admired Corporate Cultures™ of 2023 Award

STEMCELL Technologies, Canada’s largest biotechnology company, has received the Canada’s Most Admired Corporate Cultures™ of 2023 award by Waterstone Human Capital.

November 24, 2023
·
3 min read
Calliditas’ partner Everest Medicines announces China NMPA’s approval of Nefecon® for the treatment of primary IgA nephropathy

Calliditas Therapeutics AB announced that its partner Everest Medicines announced that China’s National Medical Products Administration has approved Nefecon® for the treatment of primary immunoglobulin A nephropathy in adults at risk of disease progression.

November 24, 2023
·
2 min read
Genetown

Sosei Heptares to Regain Full Ownership of GSK4381406*, a Clinic-ready, First-in-Class Oral GPR35 Agonist for Inflammatory Bowel Disease

Sosei Group Corporation announces it has initiated discussions with GSK to regain full ownership of GSK4381406, a highly selective first-in-class, oral GPR35 agonist in development under a Global Collaboration and License Agreement with GSK as a potential new treatment for Inflammatory Bowel Diseases.

November 24, 2023
·
7 min read
Health Catalyst to Participate in Upcoming Investor Conferences - November 24, 2023

Health Catalyst, Inc. today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of FP&A and Investor Relations, will participate in the following upcoming investor conferences.

November 24, 2023
·
1 min read
Business

Biovica International’s Invitation to Webcast for Q2 2023/2024

Biovica International publishes its interim report for the second quarter 2023/2024, on November 28 at 08:00 CET.

November 24, 2023
·
1 min read
Theratechnologies Receives 2023 CQDM ADRIQ RSRI Innovation Award

Theratechnologies Inc. today announced receipt of the 2023 Industrial Research Sectoral Group (RSRI) Innovation Award from the CQDM (formerly known as the Québec Consortium for Drug Discovery) and the Association for the Development of Research and Innovation of Québec (ADRIQ).

November 24, 2023
·
7 min read
Pharm Country

Insight Pharmaceuticals Issues Voluntary Nationwide Recall of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder Due to the Presence of Benzene

Insight Pharmaceuticals, a Prestige Consumer Healthcare Inc. company (“Insight”), is voluntarily recalling two lots of TING® 2% Miconazole Nitrate Athlete’s Foot Spray Antifungal Spray Powder to the consumer level.

November 24, 2023
·
3 min read
Business

Er-Kim Pharmaceuticals Supports Worldwide Prevention of Antimicrobial Resistance (AMR)

Er-Kim Pharmaceuticals joins the industry to collaborate on the prevention of antimicrobial resistance (AMR) in support of World AMR Awareness Week, a global campaign to promote understanding of antimicrobial resistance (AMR).

November 24, 2023
·
3 min read
China’s First NDA for a KRAS G12C Inhibitor: NMPA Accepts New Drug Application for GFH925 and Grants GFH925 with Priority Review Designation

GenFleet Therapeutics today announced the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA) of China has accepted the New Drug Application (NDA) for GFH925.

November 24, 2023
·
6 min read
Bio NC

Humacyte to Present at the Piper Sandler 35th Annual Healthcare Conference

Humacyte, Inc. today announced that Laura Niklason, M.D., Ph.D., Founder, President, and Chief Executive Officer, and Dale Sander, Chief Financial Officer, will present at the Piper Sandler 35th Annual Healthcare Conference, in New York, NY on November 30, 2023.

November 24, 2023
·
2 min read